相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables
Andrea de Bartolomeis et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016
Fiona J. Charlson et al.
SCHIZOPHRENIA BULLETIN (2018)
COGNITIVE CORRELATES OF THE NEGATIVE SYMPTOMS EXPRESSIVE AND EXPERIENTIAL DEFICIT FACTORS IN PSYCHOSIS
Serge Sevy et al.
SCHIZOPHRENIA BULLETIN (2018)
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses
Felice Iasevoli et al.
PSYCHIATRY RESEARCH (2018)
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
Euitae Kim et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients
Felice Iasevoli et al.
PSYCHIATRY RESEARCH (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
Amy L. Gillespie et al.
BMC PSYCHIATRY (2017)
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
Elias Mouchlianitis et al.
SCHIZOPHRENIA BULLETIN (2016)
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
Felice Iasevoli et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
The relationship between negative symptom subdomains and cognition
J. Lim et al.
PSYCHOLOGICAL MEDICINE (2016)
Brain-imaging studies of treatment-resistant schizophrenia: a systematic review
Elias Mouchlianitis et al.
LANCET PSYCHIATRY (2016)
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Paolo Fusar-Poli et al.
SCHIZOPHRENIA BULLETIN (2015)
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
James L. Kennedy et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia
Silvana Galderisi et al.
WORLD PSYCHIATRY (2014)
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment
Felice Iasevoli et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2013)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Stefan Leucht et al.
LANCET (2009)
The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population
Simona Anselmetti et al.
NEUROLOGICAL SCIENCES (2008)
Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls
Michael T. Compton et al.
SCHIZOPHRENIA RESEARCH (2007)
分享论文
